Centerbridge Partners and a consortium including PAI Partners & Goldman Sachs Capital Partners are reportedly to make final bids for Kimberly-Clark (KMB -4.3%) European tissue business.
The business, whose brands include Andrex in the UK & Ireland, as well as Hakle and Tela, is expected to be valued at ~€1B-€2B (~$1.2B)
Final bids are due in late October
Now read: Procter & Gamble: Bulls Vs. Bears »
Subscribe for full text news in your inbox